Solução cristaloide isotônica balanceada/solução de eletrólitos ph 7,4 (concentração iônica meq/l sódio 140, potássio 5, magnésio 3, cloreto 98 acetato 27, gluconato 23) e seu processo de não padronização no âmbito do Distrito Federal
DOI:
https://doi.org/10.51208/saudeinovacao.v2i1.54Abstract
The medicine called balanced isotonic crystalloid solution/electrolyte solution pH 7.4 (ionic concentration mEq/L sodium 140, potassium 5, magnesium 3, chloride 98 acetate 27, gluconate 23) can be used before or after the infusion of blood through the same infusion set (structure designed to introduce a large volume of liquid into the bloodstream), added or infused together with blood components, or used as a diluent in the transfusion of packed red blood cells (red blood cells) Standardization of this drug in the List of Medicines was requested of the Federal District (REME-DF). For this, a health technology assessment tool was used, through a bibliographic survey in Medline databases via Pubmed; Embase, Cochrane Library and Biblioteca Virtual em Saúde - BVS. In view of this request, received by the CCFT, an analysis was carried out considering up-to-date literature on this product. 267 articles were found, 2 of which were included in this analysis. In conclusion, due to the lack of robust literature regarding the superiority of this product compared to others standardized in the SES-DF, this drug was not standardized within the Federal District.
References
BAXTER.https://buladeremedio.net/pdfs/plasma_lyte_2773392019_11111481-repaired.pdf Acesso em: 24.11.2021
Weinberg L, Collins N, Van Mourik K, Tan C, Bellomo R. Plasma-Lyte 148: A clinical review. World J Crit Care Med. 2016 Nov 4;5(4):235-250. doi: 10.5492/wjccm.v5.i4.235. PMID: 27896148; PMCID: PMC5109922.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche P, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009 Jul;6(7):e1000100.
Ellekjaer KL, Perner A, Jensen MM, Møller MH. Lactate versus acetate buffered intravenous crystalloid solutions: a scoping review. Br J Anaesth. 2020 Nov;125(5):693-703. doi: 10.1016/j.bja.2020.07.017. Epub 2020 Sep 4. PMID: 32892982.
Pfortmueller CA, Fleischmann E. Acetate-buffered crystalloid fluids: Current knowledge, a systematic review. J Crit Care. 2016 Oct;35:96-104. doi: 10.1016/j.jcrc.2016.05.006. Epub 2016 May 12. PMID: 27481742.
Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7:10.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Juliana Carvalho Rocha Alves da Silva, Marcus Tulio Batista Silva, Walleska Fidelis Gomes Borges

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Os autores declaram aceitar a política de direito autoral praticada pela revista. A submissão de originais para a Revista Saúde e Inovação implica na transferência, pelos autores, dos direitos de publicação impressa e digital. Os direitos autorais para os artigos publicados nesta revista são do autor, com direitos da revista sobre a primeira publicação. Os autores somente poderão utilizar os mesmos resultados em outras publicações indicando claramente a Revista Saúde e Inovação como o meio da publicação original. Em virtude de tratar-se de um periódico de acesso aberto, é permitido o uso gratuito dos artigos, principalmente em aplicações educacionais e científicas, desde que citada a fonte. A Revista Saúde e Inovação adota a licença Creative Commons Atribuição 4.0 Internacional (CC BY 4.0): https://creativecommons.org/licenses/by/4.0/deed.pt_BR